Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Mar 17:7:32.
doi: 10.1186/1471-2474-7-32.

Immunogenicity of unprocessed and photooxidized bovine and human osteochondral grafts in collagen-sensitive mice

Affiliations
Comparative Study

Immunogenicity of unprocessed and photooxidized bovine and human osteochondral grafts in collagen-sensitive mice

Jill S Kawalec-Carroll et al. BMC Musculoskelet Disord. .

Abstract

Background: Autologous and allogeneic osteochondral grafts have been used to repair damaged or diseased cartilage. There are drawbacks to both of these methods, however. Another possible source for osteochondral grafting is photooxidized xenograft scaffolds. The purpose of this study was to evaluate the adaptive immune response to unprocessed and photooxidized xenogeneic osteochondral grafts in a collagen-sensitive mouse model.

Methods: Unprocessed and photooxidized bovine and human osteochondral grafts were used. The grafts were implanted subcutaneously in collagen-sensitive DBA/1LacJ mice for four or twelve weeks. ELISPOT assays were conducted with spleen cells to evaluate the number of collagen-specific T cells that produce IL-2, IL-4, IL-5 or IFN-gamma. Serum was collected and ELISA assays were performed to determine the titers of collagen-specific and total IgG, IgG1, IgG2a, or IgM antibodies. Histology was conducted on the retrieved osteochondral grafts.

Results: Results indicated that, with respect to adaptive T cell immunity, the photooxidized bovine grafts, unprocessed human grafts and photooxidized human grafts did not induce a significant response to collagen. The unprocessed bovine grafts, however, were slightly more immunogenic, inducing a weak immune response. With respect to antibody production, the bovine grafts were less immunogenic than the human grafts. Bovine collagen-specific IgG antibodies were not induced by these grafts, but production of IgM after twelve weeks was observed with both the unprocessed and photooxidized bovine grafts. In contrast, photooxidized human osteochondral grafts induced IgG1 and IgG2a antibodies, while the unprocessed human grafts did not. Pre-existing human collagen-specific IgM antibodies were present in all mice, including sham-operated negative controls that did not receive an implant. Histological analysis revealed some degree of fibrous encapsulation and inflammatory infiltrations in both bovine and human implants, whether unprocessed or photooxidized.

Conclusion: Both bovine and human cartilage grafts showed weak, but clear immunogenicity in the DBA/1LacJ mice, indicating that immunogenic collagen was still contained in the grafts, even after cleaning and photooxidation. The process of photooxidation is still important in osteochondral grafting, since it stabilizes the surface of the cartilage by cross-linking the collagen fibers, and allows for immediate load bearing and joint resurfacing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cytokine response to bovine collagen (4 weeks). The average number of cytokine-producing T cells per million spleen cells in response to a challenge from bovine collagen and osteochondral grafts at four weeks.
Figure 2
Figure 2
Cytokine response to bovine collagen (12 weeks). The average number of cytokine-producing T cells per million spleen cells in response to a challenge from bovine collagen and osteochondral grafts at twelve weeks.
Figure 3
Figure 3
Cytokine response to human collagen (4 weeks). The average number of cytokine-producing T cells per million spleen cells in response to a challenge from human collagen and osteochondral grafts at four weeks.
Figure 4
Figure 4
Cytokine response to human collagen (12 weeks). The average number of cytokine-producing T cells per million spleen cells in response to a challenge from human collagen and osteochondral grafts at twelve weeks.

References

    1. Hangody L, Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am. 2003;85:25–32. - PubMed
    1. Hangody L, Rathonyi GK, Duska Z, Vasarhelyi G, Fules P, Modis L. Autologous osteochondral mosaicplasty: surgical technique. J Bone Joint Surg Am. 2004;86:65–72. - PubMed
    1. Kodama N, Honjo M, Maki J, Hukuda S. Osteochondritis dissecans of the talus treated with the mosaicplasty technique: a case report. J Foot Ankle Surg. 2004;43:195–198. doi: 10.1053/j.jfas.2004.03.003. - DOI - PubMed
    1. LaPrade RF, Botker JC. Donor-site morbidity after osteochondral autograft transfer procedures. Arthroscopy. 2004;20:e69–73. - PubMed
    1. Gross AE, Shasha N, Aubin P. Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res. 2005:79–87. doi: 10.1097/01.blo.0000165845.21735.05. - DOI - PubMed

Publication types